2m 2m 2m 2m 2m 2m 2m
CVS Health (CVS)
NYSE
$101.57+$0.27 (+0.27%)
Price as of Jun 23, 2026 4:10 PM EDT- $129.3BMarket Cap
- 57.17%1-Year Change
- Healthcare PlansIndustry
CVS Health (CVS)
$101.57+$0.27 (+0.27%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 402.1B +7.85% | 372.8B +4.20% | 357.8B +10.95% | 322.5B +10.39% | |
Cost of Revenue | 221.2B +7.21% | 206.3B -4.98% | 217.1B +10.26% | 196.9B +12.00% | |
Gross Profit | 180.9B +8.63% | 166.5B +18.37% | 140.7B +12.03% | 125.6B +7.97% | |
Sales and Marketing Expense | 970.0M -1.92% | 989.0M +0.41% | 985.0M +32.21% | 745.0M +42.45% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 4.6B +0.20% | 4.6B +5.29% | 4.4B +2.80% | 4.2B -5.87% | |
Total Operating Expenses | 397.4B +9.09% | 364.3B +5.89% | 344.0B +9.31% | 314.7B +12.84% | |
Operating Profit | 4.7B -45.28% | 8.5B -38.03% | 13.7B +77.42% | 7.7B -41.29% | |
Interest Income | 1.3B -36.54% | 2.1B +23.76% | 1.7B +41.22% | 1.2B +12.24% | |
Interest Expense | N/A N/A | N/A N/A | -2.7B +16.22% | -2.3B -8.63% | |
Interest Income and Expense and Net | 1.3B -36.54% | 2.1B +318.19% | -962.0M -11.42% | -1.1B -24.21% | |
Total Nonoperating Income and Expense | 112.0M +13.13% | 99.0M +12.50% | 88.0M -47.93% | 169.0M -7.14% | |
Income before Taxes | 2.1B -65.26% | 6.1B -44.97% | 11.2B +98.53% | 5.6B -45.99% | |
Income Taxes | 408.0M -73.88% | 1.6B -44.31% | 2.8B +91.73% | 1.5B -41.99% | |
Extraordinary Items | 607.0M +299.34% | 152.0M 0.00% | 152.0M N/A | N/A N/A | |
Net Income | 1.8B -61.68% | 4.6B -44.70% | 8.3B +101.11% | 4.1B -47.55% | |
Net Income from Continuing Operations Applicable to Common | 2.1B -65.26% | 6.1B -44.97% | 11.2B +98.53% | 5.6B -45.99% | |
Basic EPS and Net Income | 1.40 -61.85% | 3.67 -43.45% | 6.49 +105.38% | 3.16 -47.33% | |
Diluted EPS and Net Income | 1.39 -62.02% | 3.66 -43.43% | 6.47 +106.05% | 3.14 -47.23% | |
Basic Weighted Average Shares | 1.3B +0.64% | 1.3B -2.02% | 1.3B -2.06% | 1.3B -0.53% | |
Diluted Weighted Average Shares | 1.3B +0.71% | 1.3B -2.17% | 1.3B -2.49% | 1.3B -0.45% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.5B -1.55% | 8.6B +4.76% | 8.2B -36.69% | 12.9B +37.60% | |
Short-Term Investments | 2.1B -10.88% | 2.4B -26.14% | 3.3B +17.31% | 2.8B -10.88% | |
Cash and Cash Equivalents and Short-Term Investments | 10.6B -3.59% | 11.0B -4.03% | 11.5B -27.14% | 15.7B +25.53% | |
Total Current Assets | 74.7B +8.84% | 68.6B +1.16% | 67.9B +3.31% | 65.7B +9.46% | |
Accumulated Depreciation | 24.7B +5.53% | 23.4B +13.28% | 20.7B -3.65% | 21.5B +4.01% | |
Property and Plant and Equipment and Net | 13.1B +0.69% | 13.0B -1.44% | 13.2B +2.41% | 12.9B -0.18% | |
Total Long-Term Assets | 5.1B +6.80% | 4.8B +2.85% | 4.7B +0.87% | 4.6B -1.99% | |
Total Assets | 253.5B +0.13% | 253.2B +1.40% | 249.7B +9.40% | 228.3B -2.03% | |
Income Taxes Payable | 3.8B +0.68% | 3.8B -11.71% | 4.3B +11.11% | 3.9B -38.12% | |
Total Short-Term Debt | 4.1B -29.17% | 5.7B +93.24% | 3.0B +67.15% | 1.8B -57.72% | |
Total Current Liabilities | 88.7B +4.83% | 84.6B +6.84% | 79.2B +13.56% | 69.7B +2.84% | |
Total Long-Term Debt | 60.5B -0.04% | 60.5B +3.22% | 58.6B +16.17% | 50.5B -2.88% | |
Total Long-Term Liabilities | 4.8B -12.04% | 5.4B -12.56% | 6.2B -7.74% | 6.7B +253.57% | |
Total Liabilities | 178.2B +0.38% | 177.5B +2.54% | 173.1B +10.28% | 157.0B -0.42% | |
Retained Earnings | 61.2B -2.61% | 62.8B +2.00% | 61.6B +9.72% | 56.1B +2.26% | |
Total Stockholders Equity | 75.2B -0.46% | 75.6B -1.18% | 76.5B +7.67% | 71.0B -5.41% | |
Total Shares Outstanding | 1.3B +0.87% | 1.3B -2.17% | 1.3B -0.92% | 1.3B -1.66% | |
Cash Flow | |||||
Cash from Operating Activities | 10.6B +16.82% | 9.1B -32.17% | 13.4B -17.01% | 16.2B -11.43% | |
Capital Expenditures | 2.8B +1.83% | 2.8B -8.25% | 3.0B +11.15% | 2.7B +8.21% | |
Cash from Investing Activities | -5.9B -22.88% | -7.6B -63.55% | -20.9B +313.89% | -5.0B -4.07% | |
Dividends Paid | 3.4B +0.71% | 3.4B +7.69% | 3.1B +7.74% | 2.9B +10.74% | |
Cash from Financing Activities | -4.9B +335.24% | -1.1B -142.30% | 2.7B +125.51% | -10.5B -7.40% | |
Financials Ratio | |||||
Gross Margin | 44.99% +0.73% | 44.67% +13.60% | 39.32% +0.97% | 38.94% -2.20% | |
Operating Margin | 1.16% -49.26% | 2.28% -40.53% | 3.84% +59.91% | 2.40% -46.81% | |
Return on Assets | 0.70% -61.97% | 1.83% -47.45% | 3.49% +94.07% | 1.80% -47.27% | |
Return on Equity | 2.35% -61.37% | 6.07% -46.36% | 11.32% +99.22% | 5.68% -48.13% | |
Revenue Growth | 7.85% +86.78% | 4.20% -61.63% | 10.95% +5.37% | 10.39% +19.31% | |
Current Ratio | 0.84 +3.83% | 0.81 -5.32% | 0.86 -9.02% | 0.94 +6.43% | |
Cash Ratio | 0.10 -6.11% | 0.10 -1.93% | 0.10 -44.23% | 0.19 +33.81% | |
Debt-to-Equity Ratio | 0.86 -2.12% | 0.88 +8.85% | 0.81 +9.51% | 0.74 -1.67% | |
Debt-to-Assets Ratio | 0.25 -2.67% | 0.26 +6.08% | 0.25 +7.78% | 0.23 -5.06% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow